Article info
PDF4th Ovarian Cancer Consensus Conference
Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
- Address correspondence and reprint requests to Jonathan A. Ledermann, BSc, MD, FRCP, UCL/H Comprehensive Biomedical Research Centre, Cancer Research UK and UCL Cancer Trials Centre, 90 Tottenham Court Rd, London, W1T 4TJ, United Kingdom. E-mail: j.ledermann{at}ctc.ucl.ac.uk.
Citation
Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
Publication history
- Received February 1, 2011
- First published April 1, 2011.
Online issue publication
June 17, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2011 by IGCS and ESGO